Pensionfund DSM Netherlands Decreases Position in National Health Investors, Inc. (NYSE:NHI)

Pensionfund DSM Netherlands decreased its position in shares of National Health Investors, Inc. (NYSE:NHI) by 60.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,000 shares of the real estate investment trust’s stock after selling 12,000 shares during the quarter. Pensionfund DSM Netherlands’ holdings in National Health Investors were worth $554,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the company. Zimmer Partners LP bought a new position in National Health Investors in the 3rd quarter valued at approximately $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of National Health Investors by 332.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust’s stock worth $20,370,000 after purchasing an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock valued at $71,651,000 after purchasing an additional 123,596 shares in the last quarter. Waterfront Capital Partners LLC purchased a new stake in shares of National Health Investors during the third quarter valued at $10,097,000. Finally, Easterly Investment Partners LLC bought a new stake in National Health Investors in the 3rd quarter worth about $5,632,000. Hedge funds and other institutional investors own 62.51% of the company’s stock.

Analyst Upgrades and Downgrades

NHI has been the topic of several research analyst reports. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Bank of America started coverage on National Health Investors in a research note on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. Truist Financial lowered their target price on National Health Investors from $78.00 to $72.00 and set a “hold” rating on the stock in a report on Monday, December 23rd. Finally, Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price target for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors has an average rating of “Moderate Buy” and a consensus target price of $75.33.

National Health Investors Trading Down 1.3 %

NYSE:NHI traded down $0.90 during midday trading on Monday, hitting $68.30. 14,026 shares of the company traded hands, compared to its average volume of 197,478. The firm has a market capitalization of $3.10 billion, a P/E ratio of 23.47, a P/E/G ratio of 4.86 and a beta of 1.06. The firm’s fifty day moving average is $74.60 and its 200-day moving average is $75.87. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. During the same quarter in the previous year, the firm earned $1.08 EPS. National Health Investors’s revenue was up 1.7% compared to the same quarter last year. On average, sell-side analysts predict that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.60 dividend on an annualized basis and a yield of 5.27%. National Health Investors’s payout ratio is 123.71%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.